Search

AtriCure Inc

Закрыт

СекторЗдравоохранение

58.13 -1.21

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

57.67

Макс.

59.79

Ключевые показатели

By Trading Economics

Доход

8.8M

9M

Продажи

12M

154M

P/E

Средняя по отрасли

265.667

56.432

Прибыль на акцию

0.18

Рентабельность продаж

5.83

Сотрудники

1,350

EBITDA

-3.8M

3.2M

Рекомендации

By TipRanks

Рекомендации

Активная покупка

Прогноз на 12 месяцев

-5.34% downside

Дивиденды

By Acuity

Следующий отчет о доходах

28 окт. 2026 г.

Рыночная статистика

By TradingEconomics

Рыночная капитализация

1.1B

2.8B

Предыдущая цена открытия

59.34

Предыдущая цена закрытия

58.13

Новостные настроения

By Acuity

34%

66%

56 / 339 Рейтинг в Healthcare

AtriCure Inc График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

18 сент. 2026 г., 20:02 UTC

AtriCure Inc shares fell sharply, breaking a recent pattern of higher daily closes amid unusually high market volume.

17 сент. 2026 г., 20:07 UTC

AtriCure Inc is advancing in today's trading session, continuing a trend that has seen the stock rise significantly since Wednesday's close.

16 сент. 2026 г., 19:44 UTC

AtriCure Inc is trading higher, maintaining a price above its 20-day moving average and marking gains in four consecutive sessions.

15 сент. 2026 г., 20:07 UTC

News

AtriCure Inc's stock is higher following an insider sale of 5,313 shares by Board Member Regina E. Groves for about $288,070.

14 сент. 2026 г., 20:07 UTC

News

AtriCure reports gross revenue of $534.53 million and a net income loss of $11.45 million, with shares advancing amid positive market sentiment.

11 сент. 2026 г., 22:11 UTC

AtriCure Inc. shares are lower in after-market trading, continuing a decline since Friday's close amid notably weak overall market conditions.

9 сент. 2026 г., 20:07 UTC

AtriCure Inc. shares are lower today, following a notable drop at the open amid broader market volatility. No specific news was identified for the decline.

8 сент. 2026 г., 20:01 UTC

News

AtriCure Inc. is trading higher as analysts issue mixed ratings and price targets, with BTIG raising its target to $55.00.

3 сент. 2026 г., 20:01 UTC

AtriCure Inc shares are lower during Thursday's session, continuing a decline since Wednesday. No specific news was identified to explain the movement.

2 сент. 2026 г., 20:01 UTC

News

AtriCure Inc shares are higher following an upgrade from Needham, raising the price target to $64.00 from $45.00 while maintaining a Buy rating.

1 сент. 2026 г., 20:08 UTC

AtriCure Inc. shares are higher today, driven by gains in the Health Care Equipment sub-sector. The stock remains strong above its 20-day moving average.

31 авг. 2026 г., 19:26 UTC

AtriCure Inc's shares are lower amid broader market sentiment influenced by interest rate concerns, despite remaining above their 20-day moving average.

28 авг. 2026 г., 19:16 UTC

AtriCure Inc shares are lower today, following an early dip. Broader market concerns about inflation and growth expectations may be influencing sentiment.

26 авг. 2026 г., 19:08 UTC

News

AtriCure Inc shares are lower amid Health Care Equipment sector weakness and an insider sale of 9,370 shares valued at $458,099.

24 авг. 2026 г., 19:36 UTC

News

AtriCure's price target raised to $55 from $45 by BTIG. Shares are higher, reflecting positive sentiment on the company's growth prospects.

20 авг. 2026 г., 19:46 UTC

AtriCure Inc shares are higher today, maintaining gains since Wednesday's close, despite earlier fluctuations. The stock remains above its 20-day moving average.

19 авг. 2026 г., 20:01 UTC

AtriCure Inc shares are trading higher during Wednesday's session, continuing a strong upward trajectory since Tuesday's close, despite no specific news identified.

18 авг. 2026 г., 19:16 UTC

AtriCure Inc shares are higher today, continuing momentum from Monday's close. Broader market factors include rising U.S. Treasury yields amid inflation concerns.

17 авг. 2026 г., 22:46 UTC

AtriCure Inc is trading higher in after-market hours, with no specific news identified for the move. The stock remains above its 20-day moving average.

12 авг. 2026 г., 20:06 UTC

AtriCure Inc shares are higher today, continuing a nine-session streak of gains. The stock remains above its 20-day moving average.

11 авг. 2026 г., 22:41 UTC

AtriCure Inc shares are higher in after-market trading, continuing a recent trend of strength amid changing monetary policies from central banks.

7 авг. 2026 г., 20:03 UTC

AtriCure Inc's shares are higher during Friday's session, continuing an upward trend since Thursday's close, and remain above their 20-day moving average.

6 авг. 2026 г., 19:12 UTC

AtriCure Inc shares are higher, benefiting from an upward trend in the Health Care Equipment sub-sector. Earlier, the stock peaked before a slight pullback.

5 авг. 2026 г., 19:51 UTC

AtriCure Inc shares are higher today, despite no specific news. Broader market sentiment is cautious following ADP's disappointing employment report.

3 авг. 2026 г., 20:06 UTC

AtriCure Inc. shares are higher during Monday's session, regaining ground after an earlier pullback. Broader market trends support positive investor sentiment.

31 июл. 2026 г., 20:03 UTC

News

AtriCure shares are lower amid significant insider selling, including a $233,280 sale by Chief Scientific Officer Vinayak Doraiswamy and options exercised by Board Member Sven Wehrwein.

30 июл. 2026 г., 18:56 UTC

AtriCure Inc's shares are lower today, impacted by declines in the Health Care Equipment sub-sector. No specific company news was identified for the movement.

29 июл. 2026 г., 20:03 UTC

News

AtriCure Inc shares reached a 52-week high of $43.18 following better-than-expected quarterly earnings, despite a pullback earlier in the session.

28 июл. 2026 г., 19:21 UTC

AtriCure Inc's shares are higher today amid stronger gains in U.S. and European indices, with no specific company news identified for the movement.

27 июл. 2026 г., 20:02 UTC

News

AtriCure Inc shares are higher as the company prepares for two investor conferences and highlights CEO Michael Carrel's leadership appointment.

Сравнение c конкурентами

Изменение цены

AtriCure Inc Прогноз

Целевая цена

By TipRanks

-5.34% падение

Прогноз на 12 месяцев

Средняя 55 USD  -5.34%

Максимум 65 USD

Минимум 36 USD

Основано на мнении 8 аналитиков Wall Street, спрогнозировавших целевые цены для AtriCure Inc на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Активная покупка

8 ratings

6

Покупка

2

Удержание

0

Продажа

Настроения

By Acuity

56 / 339Рейтинг в Здравоохранение

Новостные настроения

Свидетельства восходящего тренда

Волатильность

Ниже среднего

Объем новостей (RCV)

Ниже среднего

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании AtriCure Inc

AtriCure, Inc. develops, manufactures, and sells devices for surgical ablation of cardiac tissue, exclusion of the left atrial appendage, and temporarily blocking pain by ablating peripheral nerves to medical centers in the United States, Europe, the Asia-Pacific, and internationally. The company offers Isolator Synergy Clamps, single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as the MAX Pen device that enables surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation, and ablate cardiac tissue with the same device; and the Coolrail device, which enables users to make longer linear lines of ablation. It also provides cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; EPi-Sense Systems, a single-use disposable device used for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation; cryoSPHERE probe, which provides temporary pain relief by applying cryothermic energy to targeted intercoastal peripheral nerves in the ribcage; AtriClip System, an implantable device coupled to a single-use disposable applier; and LARIAT System, a suture-based solution for soft-tissue closure. In addition, the company sells Lumitip dissectors to separate tissues to provide access to key anatomical structures that are targeted for ablation; Glidepath guides for placement of clamps; Subtle Cannula's to support access for EPi-Sense catheters; and various reusable cardiac surgery instruments. It markets and sells its products through independent distributors and direct sales personnel. The company was incorporated in 2000 and is headquartered in Mason, Ohio.